JPS6258716B2 - - Google Patents
Info
- Publication number
- JPS6258716B2 JPS6258716B2 JP54161582A JP16158279A JPS6258716B2 JP S6258716 B2 JPS6258716 B2 JP S6258716B2 JP 54161582 A JP54161582 A JP 54161582A JP 16158279 A JP16158279 A JP 16158279A JP S6258716 B2 JPS6258716 B2 JP S6258716B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- group
- enzyme
- general formula
- producing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 51
- 108090000790 Enzymes Proteins 0.000 claims description 45
- 102000004190 Enzymes Human genes 0.000 claims description 45
- 108010093096 Immobilized Enzymes Proteins 0.000 claims description 32
- 239000011148 porous material Substances 0.000 claims description 31
- 238000004519 manufacturing process Methods 0.000 claims description 25
- -1 7-aminocephem compound Chemical class 0.000 claims description 9
- 239000003957 anion exchange resin Substances 0.000 claims description 9
- 239000003456 ion exchange resin Substances 0.000 claims description 9
- 229920003303 ion-exchange polymer Polymers 0.000 claims description 9
- 239000003431 cross linking reagent Substances 0.000 claims description 8
- 230000000704 physical effect Effects 0.000 claims description 7
- 108090000623 proteins and genes Proteins 0.000 claims description 7
- 102000004169 proteins and genes Human genes 0.000 claims description 7
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims description 6
- 230000000269 nucleophilic effect Effects 0.000 claims description 6
- 239000000872 buffer Substances 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 3
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 claims description 3
- 125000001302 tertiary amino group Chemical group 0.000 claims description 3
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 239000012736 aqueous medium Substances 0.000 claims 1
- 238000000034 method Methods 0.000 description 29
- 239000011347 resin Substances 0.000 description 21
- 229920005989 resin Polymers 0.000 description 21
- 230000000694 effects Effects 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 9
- 239000000243 solution Substances 0.000 description 7
- 230000003100 immobilizing effect Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000008363 phosphate buffer Substances 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- HSHGZXNAXBPPDL-HZGVNTEJSA-N 7beta-aminocephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H]([NH3+])[C@@H]12 HSHGZXNAXBPPDL-HZGVNTEJSA-N 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003139 buffering effect Effects 0.000 description 2
- HOKIDJSKDBPKTQ-GLXFQSAKSA-N cephalosporin C Chemical compound S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H](N)C(O)=O)[C@@H]12 HOKIDJSKDBPKTQ-GLXFQSAKSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- HUWSZNZAROKDRZ-RRLWZMAJSA-N (3r,4r)-3-azaniumyl-5-[[(2s,3r)-1-[(2s)-2,3-dicarboxypyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-5-oxo-4-sulfanylpentane-1-sulfonate Chemical compound OS(=O)(=O)CC[C@@H](N)[C@@H](S)C(=O)N[C@@H]([C@H](C)CC)C(=O)N1CCC(C(O)=O)[C@H]1C(O)=O HUWSZNZAROKDRZ-RRLWZMAJSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241001478312 Comamonas sp. Species 0.000 description 1
- 239000005057 Hexamethylene diisocyanate Substances 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- OKIZCWYLBDKLSU-UHFFFAOYSA-M N,N,N-Trimethylmethanaminium chloride Chemical compound [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- GTFMAONWNTUZEW-UHFFFAOYSA-N glutaramic acid Chemical compound NC(=O)CCCC(O)=O GTFMAONWNTUZEW-UHFFFAOYSA-N 0.000 description 1
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16158279A JPS5685298A (en) | 1979-12-14 | 1979-12-14 | Preparation of 7-aminocephem compound |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16158279A JPS5685298A (en) | 1979-12-14 | 1979-12-14 | Preparation of 7-aminocephem compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5685298A JPS5685298A (en) | 1981-07-11 |
| JPS6258716B2 true JPS6258716B2 (de) | 1987-12-07 |
Family
ID=15737857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP16158279A Granted JPS5685298A (en) | 1979-12-14 | 1979-12-14 | Preparation of 7-aminocephem compound |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5685298A (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4981789A (en) * | 1987-03-18 | 1991-01-01 | Merck & Co., Inc. | One-step enzymatic conversion of cephalosporin C and derivatives to 7-aminocephalosporanic acid and derivatives |
| US5104800A (en) * | 1989-06-27 | 1992-04-14 | Merck & Co., Inc. | One-step cephalosporin c amidase enzyme |
| ES2124714T3 (es) * | 1991-07-26 | 1999-02-16 | Lonza Ag | Procedimiento de ingenieria genetica para la preparacion de s-(+)-2,2-dimetilciclopropanocarboxamida mediante microorganismos. |
| WO2002086143A2 (en) * | 2001-04-19 | 2002-10-31 | Bioferma Murcia, S.A. | Enzymatic process for preparing cephalosporin derivatives |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5359095A (en) * | 1976-11-05 | 1978-05-27 | Asahi Chem Ind Co Ltd | Preparation of 7-aminocephem cpds. |
| JPS53139791A (en) * | 1977-05-02 | 1978-12-06 | Asahi Chem Ind Co Ltd | Preparation of 7-aminocephem compounds |
-
1979
- 1979-12-14 JP JP16158279A patent/JPS5685298A/ja active Granted
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5359095A (en) * | 1976-11-05 | 1978-05-27 | Asahi Chem Ind Co Ltd | Preparation of 7-aminocephem cpds. |
| JPS53139791A (en) * | 1977-05-02 | 1978-12-06 | Asahi Chem Ind Co Ltd | Preparation of 7-aminocephem compounds |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5685298A (en) | 1981-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1352965B1 (de) | Verfahren zur herstellung einer amidverbindung unter verwendung eines mikrobiellen katalysators | |
| JP2020500555A (ja) | メチロピラ及びその選択的分割による（Ｓ）−α−エチル−２−オキソ−１−ピロリジン酢酸塩の調製における使用 | |
| JPS6258716B2 (de) | ||
| US6630338B2 (en) | Removing deacetylase contaminant from cephalosporin C acylase using cationic surfactant | |
| CN111647634A (zh) | 一种填充床连续流不对称合成(S)-1-Boc-3-氨基哌啶的方法 | |
| JPS5928484A (ja) | Ｌ−アミノ酸の単離方法 | |
| AU603827B2 (en) | Novel preparation | |
| JPS583675B2 (ja) | 水溶液中に含まれている生化学化合物を増成又は減成する方法 | |
| EP0132998B1 (de) | Ein Verfahren zur Herstellung eines Harzmaterials an dem ein Enzym fixiert ist und eine Methode zu dessen Regeneration | |
| JP2804004B2 (ja) | Ｌ−アスパラギン酸の製造方法 | |
| JP2001270857A (ja) | アミド化合物の精製方法 | |
| JPS6131085A (ja) | 固定化微生物菌体の製造法 | |
| JP2804005B2 (ja) | Ｌ−アスパラギン酸の製造方法 | |
| JP3167546B2 (ja) | Ｌ−セリンの製造方法 | |
| EP0185379A2 (de) | Verfahren zur Herstellung von gereinigter Glukose-Isomerase | |
| JP3647065B2 (ja) | 光学活性アラニンの製造方法 | |
| JPWO2004009829A1 (ja) | メチオニンの製造法 | |
| JPS58190399A (ja) | ６−アミノペニシラン酸の製造方法 | |
| JPS6115690A (ja) | 酵素固定樹脂組成物並びにその製造方法及び再生法 | |
| JP3392865B2 (ja) | 固定化酵素調製物およびＤ―α―アミノ酸の製造法 | |
| JPS5858080B2 (ja) | ７−アミノセフエム化合物の製造法 | |
| JP4148640B2 (ja) | アスパラギン酸の製造法 | |
| JPS63160590A (ja) | Ｌ−リンゴ酸の製造法 | |
| JPH0348793B2 (de) | ||
| JPS63160583A (ja) | 固定化リパ−ゼの製造方法および該固定化リパ−ゼを用いた脂質の加水分解方法 |